https://www.sungenbiomed.com/https://www.sungenbiomed.com/about-sungen/https://www.sungenbiomed.com/technological-platforms/https://www.sungenbiomed.com/news/https://www.sungenbiomed.com/learning-and-development/https://www.sungenbiomed.com/contact.htmlhttps://www.sungenbiomed.com/sitemap.htmlhttps://www.sungenbiomed.com/privacy-policy.htmlhttps://www.sungenbiomed.com/first-show-vienna-phase-i-clinical-data-of-the-worlds-first-antibody-drug-sgc001-for-acute-myocardial-infarction-unveiled-bio-europe2025.htmlhttps://www.sungenbiomed.com/riding-the-wave-the-world-s-first-acute-myocardial-infarction-antibody-sgc001-of-sungen-biomedical-was-presented-at-u-s-j-p-morgan-conference.htmlhttps://www.sungenbiomed.com/sungen-biomedicals-world-first-new-drug-sgc001-monoclonal-antibody-receives-fda-fast-track-approval.htmlhttps://www.sungenbiomed.com/news/the-laboratory-animal-management-center-at-sungen-biomedical-is-granted.htmlhttps://www.sungenbiomed.com/benefits-compensation/https://www.sungenbiomed.com/news/sungen-biomedical-was-awarded-the-most-potential-seed-enterprise-2024-by-ey-fudan.htmlhttps://www.sungenbiomed.com/news/the-joint-application-project-of-military-medical-research-institute.htmlhttps://www.sungenbiomed.com/news/research-progress-of-sgc001-the-worlds-first-myocardial-infarction-antibody-drug.htmlhttps://www.sungenbiomed.com/news/first-china-pharmaceutical-valley-future-biological-innovative-drugs-conference.htmlhttps://www.sungenbiomed.com/news/the-first-china-pharmaceutical-valley-future-biological-innovative-drugs-conference.htmlhttps://www.sungenbiomed.com/news/techniques-for-the-preparation-of-human-monoclonal-antibodies.htmlhttps://www.sungenbiomed.com/news/sungen-biomedical-won-the-first-prize-of-beijing-science-and-technology-progress-award.htmlhttps://www.sungenbiomed.com/news/from-acceleration-of-the-research-and-development-of-fic-antibodies-by-ai-to-exploration.htmlhttps://www.sungenbiomed.com/news/create-a-new-chapter-in-the-research-and-development-of-biological-innovative-drugs.htmlhttps://www.sungenbiomed.com/development-history/https://www.sungenbiomed.com/news/opening-ceremony-of-the-national-human-brain-health-project-joint-laboratory-was-held.htmlhttps://www.sungenbiomed.com/news/sungen-biomedical-and-taizhou-peoples-hospital-officially-signed-a-contract.htmlhttps://www.sungenbiomed.com/news/nature-reveals-that-the-asgr1-gp73-axis-is-a-potential-therapeutic-target-for-liver-injury.htmlhttps://www.sungenbiomed.com/news/x-gen-ai-new-drug-discovery-and-design-research-center-published.htmlhttps://www.sungenbiomed.com/news/xinhua-finance-ai-enables-chinas-pharmaceutical-valley-to-accelerate-the-new-way.htmlhttps://www.sungenbiomed.com/news/china-pharmaceutical-valley-relies-on-artificial-intelligence.htmlhttps://www.sungenbiomed.com/news/beijing-daily-to-help-medical-treatment-by-the-wisdom-of-science-and-technology.htmlhttps://www.sungenbiomed.com/news/jie-du-was-selected-as-percent-of-global-scientists-with-lifetime-scientific-impact.htmlhttps://www.sungenbiomed.com/innovation-achievements/https://www.sungenbiomed.com/scientific-frontiers/https://www.sungenbiomed.com/news/sungen-biomedical-won-2024-top-10-innovative-pharmaceutical-enterprises-selected.htmlhttps://www.sungenbiomed.com/honors-and-qualifications/https://www.sungenbiomed.com/world-heart-attack-day-brtv-is-it-true-that-a-single-shot-can-cure-the-heart-attack.htmlhttps://www.sungenbiomed.com/news/the-first-china-pharmaceutical-valley-future-biological-innovative-drug-conference.htmlhttps://www.sungenbiomed.com/news/sungen-to-present-at-the-43rd-annual-j.p.-morgan-healthcare-conference.htmlhttps://www.sungenbiomed.com/the-classic-formulation-of-antibody-drugs.htmlhttps://www.sungenbiomed.com/three-major-forms-of-antibody-therapy.htmlhttps://www.sungenbiomed.com/differences-between-biological-macromolecule-drugs-and-chemical-small-molecule-drugs.htmlhttps://www.sungenbiomed.com/biopharmaceutical-cmc-process.htmlhttps://www.sungenbiomed.com/another-milestone-sungen-biomedical-presented-anti-tumor-bispecific-antibody-sgt003-at-the-jp-morgan-healthcare-annual-conference.htmlhttps://www.sungenbiomed.com/components-of-anti-drug-conjugates.htmlhttps://www.sungenbiomed.com/the-role-and-development-trends-of-antibody-drugs.htmlhttps://www.sungenbiomed.com/the-mechanism-of-action-of-bispecific-antibody-therapy.htmlhttps://www.sungenbiomed.com/what-are-the-types-of-bispecific-antibodies.htmlhttps://www.sungenbiomed.com/corporate-culture/https://www.sungenbiomed.com/how-ai-accelerates-antibody-discovery.htmlhttps://www.sungenbiomed.com/how-ai-is-transforming-the-pharmaceutical-industry.htmlhttps://www.sungenbiomed.com/sungen-biomedical-is-listed-on-the-3rd-kpmg-chinas-top-50-bioinnovation-companies.htmlhttps://www.sungenbiomed.com/sungen-biomedical-obtained-the-honorary-title-of-model-collective-of-beijing-municipality.htmlhttps://www.sungenbiomed.com/opportunities-and-challenges-of-ai-powered-drug-development.htmlhttps://www.sungenbiomed.com/what-are-antibody-drugs.htmlhttps://www.sungenbiomed.com/what-is-the-difference-between-macromolecules-and-small-molecules.htmlhttps://www.sungenbiomed.com/how-ai-revolutionizes-drug-development.htmlhttps://www.sungenbiomed.com/what-are-bispecific-antibodies-and-their-therapeutic-potential.htmlhttps://www.sungenbiomed.com/monoclonal-vs.-bispecific-antibodies.htmlhttps://www.sungenbiomed.com/quality-assurance-and-quality-control-in-pharmaceutical-company.htmlhttps://www.sungenbiomed.com/ai-in-antibody-discovery.htmlhttps://www.sungenbiomed.com/zhongguancun-fic-alliance-for-global-strategic-development-of-innovative-drugs-is-established-to-help-china-break-through-the-global-of-innovative-drugs.htmlhttps://www.sungenbiomed.com/a-major-breakthrough-a-phase-ib-clinical-study-of-sgc001-a-global-pioneer-antibody-drug-for-acute-myocardial-infarction-by-sungen-has-achieved-positive-results.htmlhttps://www.sungenbiomed.com/news/sungen-to-showcase-china's-innovative-power-at-jpm-2026.htmlhttps://www.sungenbiomed.com/news/2026china-fic-innovation-collaboration-sumit.htmlhttps://www.sungenbiomed.com/news/chinadaily-us-china-biotech-summit-builds-bridges-for-innovative-drug-partners.htmlhttps://www.sungenbiomed.com/news/2026-jpm-focus-series-focusing-on-ctla4-dual-target-innovative-platform-sungen-released-preclinical-results-of-anti-tumor-therapeutic-bspecific-antibody-sgt003-in-cancer-treatment-for-the-first-time.htmlhttps://www.sungenbiomed.com/news/2026-china-fic-innovation-and-collaboration-summit-held-in-san-francisco-chinese-pharmaceutical-companies-showcase-innovative-achievements.htmlhttps://www.sungenbiomed.com/news/sungen-biomed-unveils-next-generation-sg-linker-payload-platform-for-adc-development-at-2026-jp-morgan-healthcare-conference.htmlhttps://www.sungenbiomed.com/news/sungen-biomedicals-sgc001-injection-is-approved-for-clinical-trials.htmlhttps://www.sungenbiomed.com/immunity-mast-cells-regulate-lung-inflammation-through-pge2-sst2/https://www.sungenbiomed.com/news/sungen-biomedical-obtains-fdas-clinical-trial-approval-of-ind-sgc001.htmlhttps://www.sungenbiomed.com/sungen-biomedical-science-news-articles-about-cell-research/https://www.sungenbiomed.com/sungen-biomedical-science-news-articles-about-nat-immunol/https://www.sungenbiomed.com/molecular-discovery-platform/https://www.sungenbiomed.com/pilot-r-d-and-production-platform/https://www.sungenbiomed.com/quality-control-platform/